Responsive upconversion nanoprobe for monitoring and inhibition of EBV-associated cancers via targeting EBNA1

Nanoscale. 2018 Aug 23;10(33):15632-15640. doi: 10.1039/c8nr05015e.

Abstract

Non-responsive emission enhancement is the disadvantage of upconversion nanomaterials (UCNM) when compared with conventional organic based agents for molecular imaging. We herein show a new strategy by conjugating NaGdF4:Yb3+,Er3+@NaGdF4 (UCNP) with peptides to achieve responsive UC emission enhancement upon binding to a targeted protein - EBNA1. EBNA1 is a well-known viral latent protein for the EBV-associated cancer. Peptide-coating of the functionalized core-shell nanoparticle diminishes upconverted emission intensity drastically. However, the peptide-coated UCNP shows selective and responsive UC emission enhancement via aggregation with the targeted protein. This phenomenon paves a new way for UCNM in molecular imaging.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Epstein-Barr Virus Nuclear Antigens / metabolism*
  • Female
  • HeLa Cells
  • Herpesvirus 4, Human*
  • Humans
  • Mice, Inbred BALB C
  • Mice, Nude
  • Molecular Imaging
  • Nanoparticles*
  • Neoplasms / therapy*
  • Neoplasms / virology*

Substances

  • Epstein-Barr Virus Nuclear Antigens
  • EBV-encoded nuclear antigen 1